EUGIA US LLC, — Bortezomib Importer Profile
Pharmaceutical Importer · #1 buyer for Bortezomib · $650.0K import value · 13 shipments · UNITED STATES · DGFT Verified
EUGIA US LLC, is the #1 importer of Bortezomib from India with $650.0K in import value and 13 verified shipments. EUGIA US LLC, holds a 3.0% market share in Bortezomib imports based in UNITED STATES. The company sources from 1 verified supplier across 8 formulations shipped to 1 country. Overall, EUGIA US LLC, imports 27 pharmaceutical products worth $66.2M across 13 therapeutic categories.
EUGIA US LLC, — Bortezomib Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Bortezomib to EUGIA US LLC,?
Verified from 13 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| EUGIA PHARMA SPECIALITIES LIMITED | $650.0K | 13 | 100.0% |
EUGIA US LLC, sources Bortezomib from 1 verified Indian supplier based on 13 customs records. The primary supplier is EUGIA PHARMA SPECIALITIES LIMITED accounting for 100.0% of imports.
How Does EUGIA US LLC, Compare to Nearest Bortezomib Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $871.4K | 20 | $43.6K |
| 1 | EUGIA US LLC, ★ | UNITED STATES | $650.0K | 13 | $50.0K |
| 7 | FRESENIUS KABI DEUTSCHLAND GMBH | GERMANY | $609.5K | 66 | $9.2K |
| 4 | EUGIA US LLC ★ | UNITED STATES | $450.0K | 9 | $50.0K |
EUGIA US LLC, ranks #1 among 498 Bortezomib importers from India. Average shipment value of $50.0K compared to the market average of $9.9K. The closest competitors by value are YUSEN LOGISTICS BENELUX BELGIUM and FRESENIUS KABI DEUTSCHLAND GMBH.
Where Does EUGIA US LLC, Import Bortezomib To?
Destination countries from 13 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $650.0K | 13 | 100.0% |
EUGIA US LLC, imports Bortezomib to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $650.0K.
What Bortezomib Formulations Does EUGIA US LLC, Import?
| Formulation | Value | Shipments |
|---|---|---|
| BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (BO | $150.0K | 3 |
| BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (BORTEZOMIB FOR INJECTION, 3.5 MG/VIAL (SDV) - US) | $150.0K | 3 |
| BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (SDV)- US (1 S PACK))NOS | $100.0K | 2 |
| BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (BORTEZOMIB FOR INJECTION 3.5MG/VIAL (SDV)- US (1 S PACK)) | $50.0K | 1 |
| BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (BORTEZOMIB FOR INJECTION 3.5MG/VIAL (SDV)- US (1 S PACK))NOS | $50.0K | 1 |
| BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (SDV)- US (1 S PACK)) | $50.0K | 1 |
| BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (BORTEZOMIB FOR INJECTION 3.5MG/VIAL (SDV) US (1 S PACK)) | $50.0K | 1 |
| BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (SDV) US (1 S PACK)) | $50.0K | 1 |
EUGIA US LLC, imports 8 distinct Bortezomib formulations from India. The top formulation is BORTEZOMIB FOR INJECTION 3.5 MG/VIAL (BO with 3 shipments worth $150.0K.
Regulatory Requirements: Importing Bortezomib into United States
What EUGIA US LLC, and other importers must comply with to import Bortezomib from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Bortezomib
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Bortezomib from India and How Much Does EUGIA US LLC, Import?
India exported $4.9M worth of Bortezomib through 1,383 shipments from 200 suppliers to 109 countries, serving 498 buyers globally. EUGIA US LLC, imports $650.0K of this total, accounting for 3.0% of India's Bortezomib exports with 13 shipments from UNITED STATES. This is verified from 13 customs shipment records covering 8 distinct formulations.
What Is the Average Order Value for EUGIA US LLC,'s Bortezomib Imports?
EUGIA US LLC,'s average Bortezomib order value is $50.0K per consignment, based on 13 shipments totaling $650.0K. EUGIA US LLC, is based in UNITED STATES and ranks #1 among all Bortezomib importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Bortezomib to EUGIA US LLC,?
EUGIA US LLC, sources Bortezomib from 1 verified Indian supplier: EUGIA PHARMA SPECIALITIES LIMITED ($650.0K, 100.0%). This is based on 13 customs records.
How Does EUGIA US LLC, Compare to Other Bortezomib Importers?
EUGIA US LLC, ranks #1 among 498 Bortezomib importers from India with a 3.0% market share. The top 3 importers are YUSEN LOGISTICS BENELUX BELGIUM ($871.4K), EUGIA US LLC, ($650.0K), FRESENIUS KABI DEUTSCHLAND GMBH ($609.5K). EUGIA US LLC, processed 13 shipments from UNITED STATES.
What Other Advanced Oncology Products Does EUGIA US LLC, Import?
EUGIA US LLC, also imports these advanced oncology products. Each links to the detailed product page.
About EUGIA US LLC,
EUGIA US LLC, imports 27 products worth $66.2M. Beyond Bortezomib, top products include Ertapenem, Pantoprazole, Meropenem, Piperacillin, Sodium. View the complete EUGIA US LLC, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bortezomib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bortezomib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: EUGIA US LLC, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as EUGIA US LLC,'s capped import value divided by total capped export value for Bortezomib across all Indian exporters.
- 5.Verified Records: This page is backed by 13 individual customs records matching EUGIA US LLC, importing Bortezomib, covering 8 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 498+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bortezomib Import Data for EUGIA US LLC,
Access order-level details, pricing data, supplier connections, and competitive analysis for EUGIA US LLC,'s Bortezomib imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
EUGIA US LLC,
Full Company Profile →
27 products · $66.2M total trade · 13 categories
EUGIA US LLC, × Bortezomib
Verified from customs records
Company Overview
Top Products by EUGIA US LLC,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for EUGIA US LLC,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bortezomib. For current order-level data, contact TransData Nexus.